Feussner G, Albanese M, Valencia A
Medizinische Universitätsklinik Heidelberg, Germany.
Atherosclerosis. 1996 Oct 25;126(2):177-84. doi: 10.1016/0021-9150(96)05870-4.
The familial lipoprotein disorder type III hyperlipoproteinemia (HLP) is usually inherited as a recessive trait. Indeed, more than 90% of affected individuals are homozygous for a receptor binding-defective isoform of apolipoprotein (apo) E, apo E2. However, some rare apo E variants have been described that dominantly (thus in a single dose) predispose to the disease. Amino acid substitutions, which are accompanied with the loss of positive charges within the proposed apo E binding-region to lipoprotein receptors, seem to be responsible in most of these cases for the dominance with respect to the expression of type III HLP. So far available data in the literature on the naturally occurring human apo E2 (Arg136-->Cys) variant are not conclusive about its recessive or dominant character. We recently identified a subject heterozygous for this mutation, presenting the typical clinical and biochemical characteristics of type III HLP. In the present study we performed further analysis of the mutation on apo E structure and function based on computer modeling. Our combined data point to a dominant influence of the apo E2 (Arg136-->Cys) variant with respect to the transmission of the disease.
家族性脂蛋白紊乱III型高脂蛋白血症(HLP)通常作为隐性性状遗传。实际上,超过90%的患者是载脂蛋白(apo)E的受体结合缺陷型异构体apo E2的纯合子。然而,已经描述了一些罕见的apo E变体,它们以显性方式(即单剂量)使个体易患该病。在大多数情况下,在所提出的apo E与脂蛋白受体结合区域内伴随着正电荷丢失的氨基酸替换似乎是导致III型HLP表达显性的原因。到目前为止,文献中关于天然存在的人类apo E2(Arg136→Cys)变体的现有数据对于其隐性或显性特征尚无定论。我们最近鉴定出一名该突变的杂合子受试者,其表现出III型HLP的典型临床和生化特征。在本研究中,我们基于计算机建模对该突变对apo E结构和功能的影响进行了进一步分析。我们的综合数据表明apo E2(Arg136→Cys)变体在疾病传播方面具有显性影响。